CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2012

Feb 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2012-02-14

Reporting Person: MCENANY PATRICK J (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-14	Common Stock, par value $0.001 per share	P	1600	$1.10	Acquired	3179147	Direct
2012-02-14	Common Stock, par value $0.001 per share	P	23400	$1.15	Acquired	3202547	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	145922	Indirect

Footnotes

F1: Shares are owned by the Reporting Person's spouse